AIQBE Incorporates Fertinagro Biotech as a New Associated Company

The Huelva Association of Chemical, Basic and Energy Industries (AIQBE ) has incorporated Fertinagro Biotech, a leading reference in the technological and sustainable fertilizer sector in Spain, as a new associated company. With this new membership, the AIQBE has a total of 21 companies.

AIQBE President José Luis Menéndez has expressed his satisfaction at the incorporation of this leading company in the sector into the Huelva Association, “an example of innovation, industrial capacity and sustainable agriculture.”

Being part of AIQBE is a strategic decision for Fertinagro Biotech

With almost 40 years of experience and presence in more than 80 countries, Fertinagro Biotech is the largest Spanish manufacturer of agricultural amino acids and has 28 industrial plants, including the largest microbial biostimulant plant in Europe.

Its director in Huelva, Alberto Ramos, has indicated that “being part of AIQBE is a strategic decision, as it offers multiple benefits that can boost growth and competitiveness. It provides us with access to privileged information on market trends, technological innovations and regulatory changes, which will allow us to anticipate and adapt more effectively to changing environmental conditions. In addition, it facilitates the creation of contact networks, opens up opportunities for collaborations, strategic alliances and gives us a stronger collective voice for the defence of common interests.”

Fertinagro Biotech is comitted to R&D&I

Dedicated to the production and marketing of products and services for plant nutrition and animal feed, as well as fertilizers for gardening, and the logistics and distribution of industrial and environmental solutions, Fertinagro Biotech serves more than 100,000 customers and has an average turnover of 700 million euros per year.

Its commitment to research and development of new products, which translates into an annual investment of five million euros in R&D&I, has resulted in 161 national and international technological patents and 16 research projects currently underway.

__

(Featured image by ANIRUDH via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Interempresas. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us